Protein kinase 2 (CK2) controls CD4+ T cell effector function in the pathogenesis of colitis

Dominguez, 2009, Protein kinase CK2 in health and disease: CK2 and its role in Wnt and NF-kappaB signaling: linking development and cancer, Cell Mol. Life Sci., 66, 1850, 10.1007/s00018-009-9153-z Duncan, 2008, Too much of a good thing: the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2, Biochim. Biophys. Acta, 1784, 33, 10.1016/j.bbapap.2007.08.017 Bian, 2013, Global screening of CK2 kinase substrates by an integrated phosphoproteomics workflow, Sci. Rep., 3, 10.1038/srep03460 Rabalski, 2016, Molecular pathways: emergence of protein kinase CK2 (CSNK2) as a potential target to inhibit survival and DNA damage response and repair pathways in cancer cells, Clin. Cancer Res., 22, 2840, 10.1158/1078-0432.CCR-15-1314 Litchfield, 2003, Protein kinase CK2: structure, regulation and role in cellular decisions of life and death, Biochem. J., 369, 1, 10.1042/bj20021469 Di Maira, 2005, Protein kinase CK2 phosphorylates and upregulates Akt/PKB, Cell Death Differ., 12, 668, 10.1038/sj.cdd.4401604 Zheng, 2011, A CK2-dependent mechanism for activation of the JAK-STAT signaling pathway, Blood, 118, 156, 10.1182/blood-2010-01-266320 Zheng, 2013, Targeting protein kinase CK2 suppresses prosurvival signaling pathways and growth of glioblastoma, Clin. Cancer Res., 19, 1, 10.1158/1078-0432.CCR-13-0265 Gibson, 2017, Protein kinase CK2 controls the fate between Th17 cell and regulatory T cell differentiation, J. Immunol., 198, 4244, 10.4049/jimmunol.1601912 Gibson, 2018, CK2 controls Th17 and regulatory T cell differentiation through inhibition of FoxO1, J. Immunol., 201, 383, 10.4049/jimmunol.1701592 Bouma, 2003, The immunological and genetic basis of inflammatory bowel disease, Nat. Rev. Immunol., 3, 521, 10.1038/nri1132 Cho, 2008, The genetics and immunopathogenesis of inflammatory bowel disease, Nat. Rev. Immunol., 8, 458, 10.1038/nri2340 Xavier, 2007, Unravelling the pathogenesis of inflammatory bowel disease, Nature, 448, 427, 10.1038/nature06005 Zenewicz, 2009, CD4 T-cell differentiation and inflammatory bowel disease, Trends Mol. Med., 15, 199, 10.1016/j.molmed.2009.03.002 Fuss, 1996, Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5, J. Immunol., 157, 1261, 10.4049/jimmunol.157.3.1261 Heller, 2005, Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution, Gastroenterology, 129, 550, 10.1016/j.gastro.2005.05.002 de Bourayne, 2017, Protein kinase CK2 controls T-cell polarization through dendritic cell activation in response to contact sensitizers, J. Leukoc. Biol., 101, 703, 10.1189/jlb.3A0715-320RR Ulges, 2015, Protein kinase CK2 enables regulatory T cells to suppress excessive T2 responses in vivo, Nat. Immunol., 16, 267, 10.1038/ni.3083 Ulges, 2016, Protein kinase CK2 governs the molecular decision between encephalitogenic TH17 cell and Treg cell development, Proc. Natl Acad. Sci. USA, 113, 10145, 10.1073/pnas.1523869113 Gibson, 2018, Protein kinase CK2: an emerging regulator of immunity, Trends Immunol., 39, 82, 10.1016/j.it.2017.12.002 Koch, 2013, Protein kinase CK2 is a critical regulator of epithelial homeostasis in chronic intestinal inflammation, Mucosal Immunol., 6, 136, 10.1038/mi.2012.57 Ostanin, 2009, T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade, Am. J. Physiol. Gastrointest. Liver Physiol., 296, G135, 10.1152/ajpgi.90462.2008 Thierfelder, 1996, Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells, Nature, 382, 171, 10.1038/382171a0 Kaplan, 1996, Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice, Nature, 382, 174, 10.1038/382174a0 Watford, 2004, Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4, Immunol. Rev., 202, 139, 10.1111/j.0105-2896.2004.00211.x Ahern, 2010, Interleukin-23 drives intestinal inflammation through direct activity on T cells, Immunity, 33, 279, 10.1016/j.immuni.2010.08.010 Macian, 2005, NFAT proteins: key regulators of T-cell development and function, Nat. Rev. Immunol., 5, 472, 10.1038/nri1632 Murphy, 2013, Specificity through cooperation: BATF-IRF interactions control immune-regulatory networks, Nat. Rev. Immunol., 13, 499, 10.1038/nri3470 Dong, 2001, ICOS co-stimulatory receptor is essential for T-cell activation and function, Nature, 409, 97, 10.1038/35051100 Grewal, 1995, Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand, Nature, 378, 617, 10.1038/378617a0 Vaeth, 2016, Store-operated Ca(2+) entry in follicular T cells controls humoral immune responses and autoimmunity, Immunity, 44, 1350, 10.1016/j.immuni.2016.04.013 Tsytsykova, 1996, The CD40L promoter contains nuclear factor of activated T cells-binding motifs which require AP-1 binding for activation of transcription, J. Biol. Chem., 271, 3763, 10.1074/jbc.271.7.3763 Martinez, 2016, Cutting edge: NFAT transcription factors promote the generation of follicular helper T cells in response to acute viral infection, J. Immunol., 196, 2015, 10.4049/jimmunol.1501841 Koch, 2015, NFATc1 deletion in T lymphocytes inhibits the allergic trait in a murine model of asthma, Clin. Exp. Allergy, 45, 1356, 10.1111/cea.12493 Chua, M. M. et al. CK2 in cancer: cellular and biochemical mechanisms and potential therapeutic target. Pharmaceuticals (Basel)10, E18 (2017). pii. Cho, 1996, Activation of STAT4 by IL-12 and IFN-a: evidence for the involvement of ligand-induced tyrosine and serine phosphorylation, J. Immunol., 157, 4781, 10.4049/jimmunol.157.11.4781 Oppmann, 2000, Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12, Immunity, 13, 715, 10.1016/S1074-7613(00)00070-4 Jostins, 2012, Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease, Nature, 491, 119, 10.1038/nature11582 Glas, 2010, Evidence for STAT4 as a common autoimmune gene: rs7574865 is associated with colonic Crohn's disease and early disease onset, PLoS ONE, 5, e10373, 10.1371/journal.pone.0010373 Moschen, 2019, IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting, Nat. Rev. Gastroenterol. Hepatol., 16, 185, 10.1038/s41575-018-0084-8 Ahmed, 2002, Joining the cell survival squad: an emerging role for protein kinase CK2, Trends Cell Biol., 12, 226, 10.1016/S0962-8924(02)02279-1 Smids, 2018, Intestinal T cell profiling in inflammatory bowel disease: linking T cell subsets to disease activity and disease course, J. Crohns Colitis, 12, 465, 10.1093/ecco-jcc/jjx160 Vaeth, 2018, NFAT control of immune function: new frontiers for an abiding trooper, F1000Res, 7, 260, 10.12688/f1000research.13426.1 Hogan, 2003, Transcriptional regulation by calcium, calcineurin, and NFAT, Genes Dev., 17, 2205, 10.1101/gad.1102703 Lee, 2004, A distal enhancer in the interferon-gamma (IFN-gamma) locus revealed by genome sequence comparison, J. Biol. Chem., 279, 4802, 10.1074/jbc.M307904200 Gomez-Rodriguez, 2009, Differential expression of interleukin-17A and -17F is coupled to T cell receptor signaling via inducible T cell kinase, Immunity, 31, 587, 10.1016/j.immuni.2009.07.009 Ghosh, 2010, Hyperactivation of nuclear factor of activated T cells 1 (NFAT1) in T cells attenuates severity of murine autoimmune encephalomyelitis, Proc. Natl Acad. Sci. USA, 107, 15169, 10.1073/pnas.1009193107 Liu, 2015, Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations, Nat. Genet., 47, 979, 10.1038/ng.3359 Liu, 1999, Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production, J. Immunol., 163, 4049, 10.4049/jimmunol.163.7.4049 Chen, 2013, Molecular mechanisms of T cell co-stimulation and co-inhibition, Nat. Rev. Immunol., 13, 227, 10.1038/nri3405 Porter, 2000, Identification of amino acid residues and protein kinases involved in the regulation of NFATc subcellular localization, J. Biol. Chem., 275, 3543, 10.1074/jbc.275.5.3543 Bleich, 2004, Refined histopathologic scoring system improves power to detect colitis QTL in mice, Mamm. Genome, 15, 865, 10.1007/s00335-004-2392-2 Mahler, 1998, Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis, Am. J. Physiol., 274, G544 McFarland, 2016, Loss of SOCS3 in myeloid cells prolongs survival in a syngeneic model of glioma, Oncotarget, 7, 20621, 10.18632/oncotarget.7992